norketamine has been researched along with Depression, Involutional in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, AK; Choo, TH; Cooper, TB; Galfalvy, HC; Grunebaum, MF; Mann, JJ; Parris, MS; Suckow, RF | 1 |
| Bai, YM; Chen, MH; Cheng, CM; Gueorguieva, R; Hong, CJ; Krystal, JH; Li, CT; Lin, WC; Su, TP; Tu, PC | 1 |
| Fassauer, GM; Hasan, M; Hofstetter, R; Link, A; Modeß, C; Oswald, S; Siegmund, W | 1 |
| Hashimoto, K | 1 |
| Brallier, JW; Charney, DS; Feder, A; Iosifescu, DV; Lapidus, KA; Levitch, CF; Murrough, JW; Parides, MK; Perez, AM; Soleimani, L | 1 |
| Brutsche, NE; Cornwell, BR; Furey, M; Grillon, C; Marquardt, CA; Salvadore, G; Zarate, CA | 1 |
1 review(s) available for norketamine and Depression, Involutional
| Article | Year |
|---|---|
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
Topics: Animals; Antidepressive Agents; Bipolar Disorder; Depressive Disorder, Major; Excitatory Amino Acid Antagonists; History, 20th Century; History, 21st Century; Humans; Ketamine; Receptors, N-Methyl-D-Aspartate | 2019 |
4 trial(s) available for norketamine and Depression, Involutional
| Article | Year |
|---|---|
Ketamine metabolite pilot study in a suicidal depression trial.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Humans; Infusions, Parenteral; Ketamine; Midazolam; Outcome Assessment, Health Care; Pilot Projects; Severity of Illness Index; Suicidal Ideation | 2019 |
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression.
Topics: Adult; Antidepressive Agents; Asian People; Blood Pressure; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Ketamine; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Taiwan; Treatment Outcome | 2017 |
A randomized controlled trial of intranasal ketamine in major depressive disorder.
Topics: Administration, Intranasal; Adult; Aged; Antidepressive Agents; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Ketamine; Male; Middle Aged; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Young Adult | 2014 |
Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Brain Mapping; Cerebral Cortex; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Electric Stimulation; Female; Fingers; Functional Laterality; Humans; Ketamine; Magnetoencephalography; Male; Middle Aged; Psychiatric Status Rating Scales; Reaction Time; Synaptic Potentials; Time Factors; Treatment Outcome | 2012 |
1 other study(ies) available for norketamine and Depression, Involutional
| Article | Year |
|---|---|
Ketamine metabolites with antidepressant effects: Fast, economical, and eco-friendly enantioselective separation based on supercritical-fluid chromatography (SFC) and single quadrupole MS detection.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Chromatography, Supercritical Fluid; Depressive Disorder, Major; Humans; Hydroxylation; Ketamine; Solvents | 2017 |